Evidence map›Paper›PMID 23111239›Full record

ArticleDiagnostic pathology2012

Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma.

Laura Macías-García, Haydee De la Hoz-Herazo, Antonio Robles-Frías, María J Pareja-Megía, Juan López-Garrido, José I López

Open access · goldAbstract readCase Reports
In one paragraph

Article in Diagnostic pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. An Unusual "Collision Tumour" of the Prostate Gland and Rectum.Canadian journal of gastroenterology & hepatology · 2016
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Laura Macías-GarcíaUnidad de gestión clínica de Oncohematología y Anatomía Patológica, Hospital Universitario de Valme, Carretera de Cádiz s/n, 41014, Sevilla, Spain. laura.macias.garcia@gmail.com
Haydee De la Hoz-Herazo
Antonio Robles-Frías
María J Pareja-Megía
Juan López-Garrido
José I López
Hospital Universitario de Valme · ESUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastrointestinal stromal tumours (GISTs) are the most common primary mesenchymal neoplasia in the gastrointestinal tract, although they represent only a small fraction of total gastrointestinal malignancies in adults (<2%). GISTs can be located at any level of the gastrointestinal tract; the stomach is the most common location (60-70%), in contrast to the rectum, which is most rare (4%). When a GIST invades into the adjacent prostate tissue, it can simulate prostate cancer. In this study, we report on a case comprising the unexpected collision between a rectal GIST tumour and a prostatic adenocarcinoma.

findingsWe describe the complexity of the clinical, endoscopic and radiological diagnosis, of the differential diagnosis based on tumour biopsy, and of the role of neoadjuvant therapy using imatinib prior to surgical treatment.

conclusionsAlthough isolated cases of coexisting GISTs and prostatic adenocarcinomas have previously been described, this is the first reported case in the medical literature of a collision tumour involving a rectal GIST and prostatic adenocarcinoma components. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1238437468776331.

Indexed as

AdenocarcinomaAntineoplastic AgentsBenzamidesBiomarkers, TumorBiopsyChemotherapy, AdjuvantDiagnosis, DifferentialGastrointestinal Stromal TumorsHumansImatinib MesylateImmunohistochemistryMagnetic Resonance ImagingMaleMiddle AgedNeoadjuvant TherapyNeoplasm InvasivenessAntineoplastic AgentsBenzamidesBiomarkers, TumorImatinib MesylatePiperazinesPyrimidines

Identifiers

PMID23111239
PMCPMC3564815
OpenAlexW2155960996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.